By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Drugs in Development Information for CCX168
Email this page to a colleague
What is the development status for investigational drug CCX168?
CCX168 is an investigational drug.
There have been 7 clinical trials for CCX168.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2016.
The most common disease conditions in clinical trials are Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, and Azotemia. The leading clinical trial sponsors are ChemoCentryx, Mario Negri Institute for Pharmacological Research, and [disabled in preview].
There are fifteen US patents protecting this investigational drug and one hundred and thirty-eight international patents.
Summary for CCX168
| US Patents | 15 |
| International Patents | 138 |
| US Patent Applications | 59 |
| WIPO Patent Applications | 20 |
| Japanese Patent Applications | 9 |
| Clinical Trial Progress | Phase 2 (2016-12-01) |
| Vendors | 17 |
Recent Clinical Trials for CCX168
| Title | Sponsor | Phase |
|---|---|---|
| Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa | ChemoCentryx | Phase 2 |
| Controlled Trial Evaluating Avacopan in C3 Glomerulopathy | ChemoCentryx | Phase 2 |
| A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis | ChemoCentryx | Phase 3 |
Clinical Trial Summary for CCX168
Top disease conditions for CCX168
Top clinical trial sponsors for CCX168
US Patents for CCX168
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| CCX168 | Try Before You Buy | C5aR antagonists | ChemoCentryx, Inc. (Mountain View, CA) | Try Before You Buy |
| CCX168 | Try Before You Buy | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | Try Before You Buy |
| CCX168 | Try Before You Buy | Oral drug dosage forms having desired drug release profiles and uses thereof | Triastek, Inc. (Nanjing, CN) | Try Before You Buy |
| CCX168 | Try Before You Buy | Processes and intermediates in the preparation of C5aR antagonists | ChemoCentryx, Inc. (Mountain View, CA) | Try Before You Buy |
| CCX168 | Try Before You Buy | Soluble C5aR antagonists | ChemoCentryx, Inc. (Mountain View, CA) | Try Before You Buy |
| CCX168 | Try Before You Buy | Compartmented pharmaceutical dosage forms | Triastek, Inc. (Nanjing, CN) | Try Before You Buy |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for CCX168
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| CCX168 | Argentina | AR077162 | 2028-12-22 | Try Before You Buy |
| CCX168 | Australia | AU2009330194 | 2028-12-22 | Try Before You Buy |
| CCX168 | Brazil | BR112012033075 | 2028-12-22 | Try Before You Buy |
| CCX168 | Brazil | BRPI0923384 | 2028-12-22 | Try Before You Buy |
| CCX168 | Canada | CA2747522 | 2028-12-22 | Try Before You Buy |
| CCX168 | Canada | CA2965223 | 2028-12-22 | Try Before You Buy |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
